Document:

Exhibit

The use of “[***]” in this Exhibit indicates that a confidential portion has been omitted pursuant to a request for confidential treatment and the omitted material has been filed separately with the Securities and Exchange Commission.

Exhibit 10.19

AMENDMENT #2 TO THE SHOP YOUR WAY REWARDS ESTABLISHMENT AGREEMENT

Dated:  February 2, 2017

THIS AMENDMENT #2, is made as of the date listed above (“Amendment Effective Date”), by and between Sears Hometown and Outlet Stores, Inc., on behalf of itself and its subsidiaries (collectively “SHO”), and Sears Holdings Management Corporation, on behalf of itself and for the benefit of its Affiliates (collectively “SHMC”) and amends that certain Shop Your Way Rewards Establishment Agreement, dated August 8, 2012, by and between SHO and SHMC (“Agreement”).  All terms capitalized herein, but not defined herein, shall have the meanings ascribed to them in the Agreement. 

WHEREAS, the Parties wish to amend certain terms in the Agreement;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, SHO and SHMC (individually or collectively referred to as the “Party” or “Parties”) agree as follows:

1.    Amendments.  As of the Amendment Effective Date, the Agreement shall be modified as follows:
(a)    Section VI.C of the Agreement is hereby amended by deleting the language of the section and substituting the following language.
Appendix VI.C describes the Points Fee that SHO will pay to SHMC in accordance with this Agreement with respect to the issuance and redemption of Points, all of which fees are non-refundable regardless of the extent to which Points are redeemed. 
(b)    Section VII of the Agreement is hereby by amended by inserting the following, new subsection VII.D, which shall immediately follow subsection VII.C:
		
	VII.D. 
	SHO’s Other Obligations. 

		
	1.
	SHO at each of its store locations shall display and promote, at the point of sale, marketing collateral for the SYW branded CITI credit card (“CITI Card”). SHMC at its expense will provide each SHO location with such marketing collateral to be displayed. 

		
	2.
	For transactions occurring in store, SHO will maintain a process that requires inquiring of each customer whether or not the customer is a Member and if the answer is affirmative asking for the customer’s Member Number. Such process will be executed prior to transaction completion.

		
	3.
	SHO will maintain a process in its POS System 1) that requires inquiring of each customer that does not self-identify as Member if the customer would like to 

    
- 1 -

The use of “[***]” in this Exhibit indicates that a confidential portion has been omitted pursuant to a request for confidential treatment and the omitted material has been filed separately with the Securities and Exchange Commission.

enroll into the Program, and 2) to enroll into the Program those of SHO’s customers that request to enroll.   
		
	4.
	SHO will maintain a process in its POS System for SHO’s customers to apply for the CITI Card.

		
	5.
	SHO will allow for the earning, awarding, and redeeming of Points at the SHO Sites (defined below). In order to accomplish this, SHO will connect the SHO Sites (or, as applicable, the shopping cart at such sites) to the appropriate SHMC API’s allowing for the earning, awarding, and redeeming of Points online. “SHO Sites” means the websites, apps, and similar digital properties that SHO owns or operates where customers purchase products. 

(c)    Section IX (Enrollment of New Members) is hereby amended by inserting the following at the end of Section IX:
SHMC will share with SHO (1) the email addresses of all Members who had enrolled in the Program at a SHO POS on or before February 2, 2017 and (2) the email addresses of all Members who enroll in the Program at a SHO POS after February 2, 2017 (the email addresses described in (1) and (2), the “SHO email addresses”); provided, however that the email addresses of Members who have opted out of receiving email communications will not be shared with SHO. Use of the SHO email addresses provided by SHMC will be subject to Section VII(C) of this Agreement. Furthermore, SHO may use the SHO email addresses to communicate with its customers (including Members who are customers) and for the purpose of conducting its business, each in accordance with its privacy policy and applicable law, and for no other purpose of any kind whatsoever, including, without limitation, the sale or renting of such email addresses to third parties.  
(d)    Appendix VI.C is hereby deleted in its entirety and replaced with the Appendix VI.C attached hereto. 
2.        Governing Law.  Section XXXVI of the Agreement is specifically restated herein by reference.
3.        No Other Amendments.  Except as expressly amended herein, the Agreement shall continue in full force and effect, in accordance with its terms, without any waiver, amendment or other modification of any provision thereof.

Signature Page Follows

    
- 2 -

The use of “[***]” in this Exhibit indicates that a confidential portion has been omitted pursuant to a request for confidential treatment and the omitted material has been filed separately with the Securities and Exchange Commission.

IN WITNESS WHEREOF, the Parties hereto have executed this Amendment #2 as of the Amendment Effective Date.

	
		
	Sears Holdings Management Corporation

By: /s/ ERIC JAFFE
Eric Jaffee
Senior Vice President, Shop Your Way
	Sears Hometown and Outlet Stores, Inc.

By: /s/ CHARLES J. HANSEN
Charles J. Hansen
Vice President, General Counsel, and Secretary

Signature Page
Amendment #2

Appendix VI.C
[***] A total of three pages were omitted and filed separately with the Securities and Exchange Commission

- 3 -FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT

EXHIBIT 10.67

FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT 

BETWEEN 

THE REGENTS OF THE UNIVERSITY OF MICHIGAN 

AND 

HEAT BIOLOGICS, INC. 

(UM FILE NUMBER 3680) 

This First Amendment to Exclusive License Agreement (this “First Amendment”), dated December 1, 2016, is by and between Heat Biologics, Inc. (“LICENSEE”) and the Regents of the University of Michigan (“MICHIGAN”). 

WHEREAS, LICENSEE and MICHIGAN entered into an Exclusive License Agreement dated July 22, 2011, (the “Agreement”); 

WHEREAS, LICENSEE is currently in possession of the Materials; 

WHEREAS, LICENSEE previously made an Annual Fee (under Paragraph 3.1(b)(1)) for 2012, 2013, 2014 and 2015 totaled at $40,000; 

WHEREAS, LICENSEE previously made a first non-creditable milestone $25,000 payment that MICHIGAN is entitled to retain; and 

WHEREAS, LICENSEE and MICHIGAN desire to modify certain provisions of the Agreement as provided herein. 

NOW THEREFORE, MICHIGAN and LICENSEE hereby agree as follows: 

1.

Paragraph 3.1(c)(1) of the Agreement is hereby deleted in its entirety. 

2.

Paragraph 5.2 of the Agreement is hereby deleted in its entirety and replaced with the following: 

5.2 As part of the diligence required by Paragraph 5.1, LICENSEE agrees to reach the following commercialization and research and development milestones for the LICENSED PRODUCTS and LICENSED PROCESSES (together the "MILESTONES") by the following dates: 

1) Completion of Phase I Clinical Trial on or before January 1, 2020. 

2) Completion of Phase II Clinical Trial on or before January 1, 2022. 

3) Completion of Phase III Clinical Trial on or before January 1, 2024. 

4) FIRST COMMERCIAL SALE on or before January 1, 2025. 

3.

MICHIGAN agrees that LICENSEE shall not owe MICHIGAN an Annual Fee (under Paragraph 3.1(b)(1)) for 2016 that was otherwise due on July 30, 2016.  Furthermore, MICHIGAN agrees that LICENSEE shall not owe MICHIGAN an Annual Fee (under Paragraph 3.1(b)(1)) for 2017, 2018, 2019 and 2020.

 

4.

Each Party each mutually releases the other Party from any breach of the Agreement that may have occurred prior to the date of this First Amendment.

5.

Except as specifically modified and amended above, all other terms and conditions of the Agreement remain unchanged and in effect and are hereby ratified and adopted as through fully set forth herein.

IN WITNESS WHEREOF, the parties hereto have entered into this First Amendment to the Agreement as of the date and year first above-written.

					
	FOR LICENSEE

	 
	FOR THE REGENTS OF THE UNIVERSITY OF MICHIGAN

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	By:

	/s/ Jeff Wolf

	 
	By:

	/s/ Kenneth J. Nisbet

	 
	Jeff Wolf

	 
	 
	Kenneth J. Nisbet

	 
	Title: CEO

	 
	 
	Assoc. Vice President for Research, Tech Transfer

	 
	Date: 12-8-16

	 
	 
	Date: 12-7-16First Amendment to Stock Purchase Agreement

EXHIBIT 10.68

FIRST AMENDMENT TO THE

STOCK PURCHASE AGREEMENT

This First Amendment to the Stock Purchase Agreement, dated March 29, 2017 (this “Amendment”), is made by and among Heat Biologics, Inc., a Delaware corporation (“Purchaser”), Pelican Therapeutics, Inc., a Delaware corporation (the “Company”) and Josiah Hornblower, as representative of the Stockholders (the “Stockholders’ Representative”).  Capitalized terms not defined herein shall have the meanings set forth in the Stock Purchase Agreement, dated as of March 7, 2017 (as amended, modified or supplemented from time to time in accordance with its terms, the “Purchase Agreement”), by and among the Purchaser, the Company, the Stockholders party thereto and the Stockholders’ Representative.

WHEREAS, pursuant to the Purchase Agreement, the Purchaser has agreed to purchase from the Stockholders, and the Stockholders have agreed to sell, the Purchased Shares, subject to the satisfaction or waiver of certain conditions set forth in the Purchase Agreement; and

WHEREAS, the parties hereto desire to amend the Purchase Agreement in accordance with Section 12.3 thereof, as hereinafter provided.

NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

1.

Amendment.  Section 6.13 of the Purchase Agreement is hereby amended and restated in its entirety as follows:

“6.13

CPRIT Agreement.  Provided that the Purchaser has made a funding commitment to Pelican in respect of the CPRIT Grant in an amount of not less than $910,231 by the close of business on April 5, 2017, the Company shall have delivered to the Purchaser a fully executed agreement with CPRIT with respect to the CPRIT Grant (the “CPRIT Agreement”) and the CPRIT Agreement shall be in full force and effect as of the Closing Date and shall not have been amended or modified as of the Closing Date.  The funding commitment by CPRIT with respect to the CPRIT Grant under the CPRIT Agreement shall not have been amended, modified or rescinded as of the Closing.”

2.

Miscellaneous.

a.

Effect on the Purchase Agreement.  Except as expressly amended or modified by this Amendment, all terms, conditions and covenants contained in the Purchase Agreement remain in full force and effect.

b.

Counterparts.  This Amendment may be executed by the parties hereto in separate counterparts, each of which when so executed and delivered shall be deemed to be an original, but all such counterparts shall together constitute one and the same instrument.  Each counterpart may consist of a number of copies hereof each signed by less than all, but together signed by all, of the parties hereto.

c.

Governing Law.  This Amendment shall be governed by and construed in accordance with the laws of the State of Delaware, without giving effect to its principles or rules of conflict of laws.

d.

Effectiveness of Amendment.  This Amendment shall become effective as of the date first set forth above. 

[Signature Page Follows]

IN WITNESS WHEREOF, the parties have executed this Amendment as of the date first written above.

 

					
	 
	 
	 
	 
	 

	THE PURCHASER:

	 

	HEAT BIOLOGICS, INC.

 

	 
	 

	By

	 

	/s/ Jeff Wolf

	 
	 

	Name:

	 

	Jeff Wolf

	 
	 

	Title:

	 

	Chief Executive Officer

	

 

	THE COMPANY:

	 

	PELICAN THERAPEUTICS, INC.

	 
	

 

	By

	 

	/s/ Josiah Hornblower

	 
	 

	Name:

	 

	Josiah Hornblower

	 
	 

	Title:

	 

	Chief Executive Officer

	

	STOCKHOLDERS’ REPRESENTATIVE:

	

 

	 

	 
	 

	By

	 

	/s/Josiah Hornblower

	 
	 

	Name:  

	 

	Josiah Hornblower

	 
	 

	Title:

	 

	Stockholders’ Representative

[Signature Page to Amendment]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}]]